2020
DOI: 10.1002/chem.202003135
|View full text |Cite
|
Sign up to set email alerts
|

The Role of Fluorine in Glycomimetic Drug Design

Abstract: Glycans are well established to play important roles at various stages of infection and disease, and ways to modulate these interactions have been sought as novel therapies. The use of native glycan structures has met with limited success, which can be attributed to their characteristic high polarity (e.g., low binding affinities) and inherently poor pharmacokinetic properties (e.g., short drug–target residence times, rapid renal excretion), leading to the development of ′glycomimetics′. Fluorinated drugs have… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
53
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 60 publications
(57 citation statements)
references
References 196 publications
(171 reference statements)
0
53
0
Order By: Relevance
“…The C-F bond has been used as a bioisostere for a number of functional groups, including C-H, C-OH, C=O, and CN [ 27 ]. The high dissociation energy (105.4 kcal/mol) of C-F bond is difficult to break and therefore less prone for metabolic transformation [ 28 ]. The incorporation of fluorine atoms or fluorinated functional group has become a growing trend in drug development, as it can be used to improve activity, improve bioavailability, and slow metabolic degradation.…”
Section: Introductionmentioning
confidence: 99%
“…The C-F bond has been used as a bioisostere for a number of functional groups, including C-H, C-OH, C=O, and CN [ 27 ]. The high dissociation energy (105.4 kcal/mol) of C-F bond is difficult to break and therefore less prone for metabolic transformation [ 28 ]. The incorporation of fluorine atoms or fluorinated functional group has become a growing trend in drug development, as it can be used to improve activity, improve bioavailability, and slow metabolic degradation.…”
Section: Introductionmentioning
confidence: 99%
“…The small size of fluorine is important in the use of fluorine in drug development, since fluorine is not too much larger than a hydrogen substituent and can often substitute sterically without compromising target binding. Such a substitution can serve to substantially moderate drug clearance, an important consideration in drug efficacy (Meanwell, 2018 ; Al‐Harthy et al ., 2020 ; Hevey, 2021 ; Richardson, 2021 ). The lower reactivity of designed organofluorine drugs with Phase I drug metabolism enzymes, typically oxygenases, is paralleled by a typically lesser biodegradation by bacterial oxygenases that act on hydrocarbon substrates in the environment.…”
Section: Fluorine Chemistry Is Different From Other Halogens Fluorine...mentioning
confidence: 99%
“…26 A variety of functional groups, including C-H, C-OH, C=O, and C≡N, have utilized the C-F bond as a bioisostere. 27 However, it is difficult to generalize the relative ability of fluorine to act similar to a hydrogen or hydroxy group, and different factors must be considered in each case. The van der Waals radius of fluorine (1.47 Å) lies between that of oxygen (1.57 Å) and hydrogen (1.2 Å) and as it is the element with the highest electronegativity, the C-F bond is almost identical to C-OH in terms of bond length and polarity.…”
Section: Introductionmentioning
confidence: 99%